Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B

J Med Chem. 2008 Dec 25;51(24):8019-26. doi: 10.1021/jm8011867.

Abstract

Mechanistic and structural studies have been carried out to investigate the molecular basis for the irreversible inhibition of human MAO-B by mofegiline. Competitive inhibition with substrate shows an apparent K(i) of 28 nM. Irreversible inhibition of MAO-B occurs with a 1:1 molar stoichiometry with no observable catalytic turnover. The absorption spectral properties of mofegiline inhibited MAO-B show features (lambda(max) approximately 450 nm) unlike those of traditional flavin N(5) or C(4a) adducts. Visible and near-UV circular dichroism spectra of the mofegiline-MAO-B adduct shows a negative peak at 340 nm with an intensity similar to that of N(5) flavocyanine adducts. The X-ray crystal structure of the mofegiline-MAO-B adduct shows a covalent bond between the flavin cofactor N(5) with the distal allylamine carbon atom as well as the absence of the fluorine atom. A mechanism to explain these structural and spectral data is proposed.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Allyl Compounds / chemistry*
  • Allyl Compounds / pharmacology*
  • Animals
  • Butylamines / chemistry*
  • Butylamines / pharmacology*
  • Carbon / chemistry
  • Chemistry, Pharmaceutical / methods*
  • Circular Dichroism
  • Crystallography, X-Ray / methods
  • Drug Design
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Hydrogen-Ion Concentration
  • Inhibitory Concentration 50
  • Molecular Conformation
  • Monoamine Oxidase / chemistry*
  • Rats
  • Recombinant Proteins / chemistry*

Substances

  • Allyl Compounds
  • Butylamines
  • Enzyme Inhibitors
  • Recombinant Proteins
  • mofegiline
  • Carbon
  • Monoamine Oxidase

Associated data

  • PDB/2VZ2